|
|
Volumn 316, Issue 5827, 2007, Pages 976-977
|
|
Putting the brakes on psychosis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEUROLEPTIC AGENT;
OLANZAPINE;
OMEGA 3 FATTY ACID;
MENTAL HEALTH;
ADOLESCENCE;
ADOLESCENT;
ADULT;
BEHAVIOR THERAPY;
BRAIN DEVELOPMENT;
COGNITIVE THERAPY;
DIABETES MELLITUS;
DISEASE PREDISPOSITION;
EARLY DIAGNOSIS;
EARLY INTERVENTION;
FAMILY THERAPY;
FATIGUE;
GENETIC SUSCEPTIBILITY;
GRAY MATTER;
GROUP THERAPY;
HOME CARE;
HUMAN;
LIFE EVENT;
MAJOR CLINICAL STUDY;
MENTAL DISEASE;
MENTAL HEALTH CARE;
METABOLIC DISORDER;
PATIENT COMPLIANCE;
PATIENT COUNSELING;
PREDICTION;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
PSYCHOSIS;
RISK BENEFIT ANALYSIS;
SCHIZOPHRENIA;
SHORT SURVEY;
SIDE EFFECT;
STRESS;
STRESS MANAGEMENT;
SUICIDE;
SYMPTOM;
TREATMENT INDICATION;
WEIGHT GAIN;
ARTICLE;
COUNSELING;
DISEASE COURSE;
PSYCHOTHERAPY;
RISK FACTOR;
ADOLESCENT;
ADULT;
ANTIPSYCHOTIC AGENTS;
COGNITIVE THERAPY;
COUNSELING;
DISEASE PROGRESSION;
HUMANS;
PSYCHOTHERAPY;
PSYCHOTIC DISORDERS;
RISK FACTORS;
|
|
EID: 34249038106
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.316.5827.976 Document Type: Short Survey |
|
Times cited : (5)
|
|
References (0)
|
